Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion

Circulation

Volumn 98, Issue 7, 1998, Pages 699-710

  Frangogiannis, Nikolaos G ^a   Lindsey, Merry L ^a   Michael, Lloyd H ^a   Youker, Keith A ^a   Bressler, Robert B ^a   Mendoza, Leonardo H ^a   Spengler, Robert N ^b   Smith, C Wayne ^a   Entman, Mark L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cells; Cytokines; Ischemia; Myocardial infarction; Reperfusion

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CYTOKINE; HISTAMINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; GENE EXPRESSION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HISTAMINE RELEASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOCYTE; LYMPH; MAST CELL DEGRANULATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0032544201     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.7.699     Document Type: Article

References (52)

1. Baumgarten W. Infarction of the heart. Am J Physiol. 1899;2:243-265.
2. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983;67:1016-1023.
3. Weisman HF, Barton T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 1990;249:146-151.
4. Simpson PJ, Todd RF III, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest. 1988;81:624-629.
5. Ma X-L, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 1992;86:937-946.
6. Entman ML, Youker KA, Shappell SB, Siegel C, Rothlein R, Dreyer WJ, Schmalstieg FC, Smith CW. Neutrophil adherence to isolated adult canine myocytes: evidence for a CD18-dependent mechanism. J Clin Invest. 1990;85:1497-1506.
7. Smith CW, Entman ML, Lane CL, Beaudet AL, Ty TI, Youker KA, Hawkins HK, Anderson DC. Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1. J Clin Invest. 1991;88:1216-1223.
8. Entman ML, Youker KA, Shoji T, Kukielka GL, Shappell SB, Taylor AA, Smith CW. Neutrophil-induced oxidative injury of cardiac myocytes: a compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest. 1992;90:1335-1345.
9. Youker KA, Smith CW, Anderson DC, Miller D, Michael LH, Rossen RD, Entman ML. Neutrophil adherence to isolated adult cardiac myocytes: induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest. 1992;89:602-609.
10. Kukielka GL, Hawkins HK, Michael LH, Manning AM, Lane CL, Entman ML, Smith CW, Anderson DC. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest. 1993;92:1504-1516.
11. Youker KA, Hawkins HK, Kukielka GL, Perrard JL, Michael LH, Ballantyne CM, Smith CW, Entman ML. Molecular evidence for induction of intercellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart. Circulation. 1994;89:2736-2746.
12. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation. 1995; 92:1866-1875.
13. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 1990;346:274-276.
14. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993;328: 257-265.
15. Ito BR, Engler RL, Del Balzo U. Role of cardiac mast cells in complement C5a-induced myocardial ischemia. Am J Physiol. 1993;264: H1346-H1354.
16. Caughey GH, Viro NF, Calonico LD, McDonald DM, Lazarus SC, Gold WM. Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining. J Histochem Cytochem. 1988;36:1053-1060.
17. Seppa HE. Rat skin main neutral protease: immunohistochemical localization. J Invest Dermatol. 1978;71:311-315.
18. Pickvance EA, Oegema TR Jr, Thompson RC Jr. Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading. J Orthop Res. 1993;11:313-323.
19. Pelletier JP, Faure MP, DiBattista JA, Wilhelm S, Visco D, Martel-Pelletier J. Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis: an immunohistochemical study. Am J Pathol. 1993;142:95-105.
20. Hawkins HK, Entman ML, Zhu JY, Youker KA, Berens K, Dore M, Smith CW. Acute inflammatory reaction after myocardial ischemic injury and reperfusion: development and use of a neutrophil-specific antibody. Am J Pathol. 1996;148:1957-1969.
21. Bergstresser PR, Tigelaar RE, Tharp MD. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol. 1984;83:214-218.
22. McBride P, Bradley D, Kaliner M. Evaluation of a radioimmunoassay for histamine measurement in biological fluids. J Allergy Clin Immunol. 1988;82:638-646.
23. Ignatowski TA, Spengler RN. Tumor necrosis factor-alpha: presynaptic sensitivity is modified after antidepressant drug administration. Brain Res. 1994;665:293-299.
24. Zucker K, Lu P, Fuller L, Asthana D, Esquenazi V, Miller J. Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E. coli. Lymphokine Cytokine Res. 1994;13:191-196.
25. Enerback L. Mast cells in rat gastrointestinal mucosa: effects of fixation. Acta Pathol Microbiol Scand. 1966;66:289-302.
26. Patella V, Marino I, Lamparter B, Arbustini E, Adt M, Marone G. Human heart mast cells: isolation, purification, ultrastructure, and immunologic characterization. J Immunol. 1995;154:2855-2865.
27. 2 in cardiac lymph: effect of superoxide dismutase and catalase during myocardial ischemia and reperfusion. Circ Res. 1990;66:1040-1044.
28. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A. 1991;88:4220-4224.
29. Ramos BF, Zhang Y, Jakschik BA. Neutrophil elicitation in the reverse passive Arthus reaction: complement-dependent and -independent mast cell involvement. J Immunol. 1994;152:1380-1384.
30. Michael LH, Lewis RM, Brandon TA, Entman ML. Cardiac lymph from conscious dogs. Am J Physiol. 1979;237:H311-H317.
31. Michael LH, Hunt JR, Weilbaecher D, Perryman MB, Roberts R, Lewis RM, Entman ML. Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. Am J Physiol. 1985;248:H350-H359.
32. Li QY, Raza-Ahmad A, Mac Aulay MA, Lalonde LD, Rowden G, Trethewey E, Dean S. The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts. Transplantation. 1992;53:1047-1051.
33. Rossen RD, Michael LH, Hawkins HK, Youker K, Dreyer WJ, Baughn RE, Entman ML. Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. Circ Res. 1994;75:546-555.
34. Linden J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci. 1994; 15:298-306.
35. Salvemini D, Masini E, Pistelli A, Mannaioni PF, Vane J. Nitric oxide: a regulatory mediator of mast cell activity. J Cardiovasc Pharmacol. 1991; 17:5258-5264.
36. Alam R, Kumar D, Anderson-Walters D, Forsythe PA. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol. 1994;152:1298-1303.
37. Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, Mackay CR, LaRosa GJ, Rossen RD, Smith CW, Entman ML. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation. 1997;95:693-700.
38. Jirik FR, Podor TJ, Hirano T, Kishimoto TK, Loskutoff DJ, Carson DA, Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 1989;142:144-147.
39. Elias JA, Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol. 1990;145:161-166.
40. Cicco NA, Lindermann A, Content J, Vandenbussche P, Lubbert M, Gauss J, Mertelsmann R, Hermann F. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood. 1990;75:2049-2052.
41. Lee JD, Swisher SG, Minehart EH, McBride WH, Economou JS. Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells. J Leukoc Biol. 1990;47:475-479.
42. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol. 1989;44:153-205.
43. Sanceau J, Kaisho T, Hirano T, Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NFκB, and Sp1 transcription factors. J Biol Chem. 1995;270:27920-27931.
44. 2 receptors in peripheral blood mononuclear cells. J Biol Chem. 1994;269:9952-9956.
45. Ley K. Histamine can induce leukocyte rolling in rat mesenteric venules. Am J Physiol 1994;267:H1017-H1023.
46. Weyrich AS, Ma X-L, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest. 1993;91:2620-2629.
47. Kubes P, Jutila M, Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest. 1995;95:2510-2519.
48. Jolly SR, Abrams GD, Romson JL, Bailie MB, Lucchesi BR. Effects of lodoxamide on ischemic reperfused myocardium. J Cardiovasc Pharmacol. 1982;4:441-448.
49. Kubes P, Granger DN. Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res. 1996;32:699-708.
50. Kanwar S, Kubes P. Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am J Physiol. 1994;267:G316-G321.
51. Kurose I, Wolf R, Grisham MB, Granger DN. Modulation of ischemia/ reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res. 1994;74:376-382.
52. Frangogiannis NG, Perrard JL, Mendoza LH, Bums AR, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML. Stem cell factor induction is associated with mast cell accumulation following canine myocardial ischemia and reperfusion. Circulation. 1998;98:687-698.